[On the pharmacokinetic behavior of the new acetylsalicylic acid derivative, 4-(acetylamido)phenyl-2-acetoxybenzoate, in animal experiments].
D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000652:urine; D001565:Benzoates / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D004952:Esters / Q000032:analysis / Q000097:blood / Q000652:urine; D007275:Injections, Intravenous; D007422:Intestines / Q000032:analysis; D007700:Kinetics; D051381:Rats; D012459:Salicylates / Q000652:urine; D013270:Stomach / Q000032:analysis; D013997:Time Factors
D001565:Benzoates; D002247:Carbon Isotopes; D004952:Esters; D012459:Salicylates; D001241:Aspirin
Zum pharmakokinetischen Verhalten des neuen Acetylsalicylsäure-Derivats, 4-(Acetylamido)phenyl-2-acetoxybenzoat, im Tierversuch.